Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil G Burnet

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Physics and Imaging in Radiation Oncology|June 26, 2020
Associations between voxel-level accumulated dose and rectal toxicity in prostate radiotherapyLeila E A Shelley, Michael P F Sutcliffe, Simon J Thomas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2009
A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry resultsGillian C Barnett, Jennifer Wilkinson, Anne M Moody, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2010
No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER studyGillian C Barnett, Charlotte E Coles, Neil G Burnet, et al.
The British Journal of Radiology|December 21, 2019
Proton beam therapy: perspectives on the National Health Service England clinical service and research programmeNeil G Burnet, Ranald I Mackay, Ed Smith, et al.
Neuro-Oncology Practice|March 18, 2024
Radiotherapy intensification for atypical and malignant meningiomas: A systematic reviewSimona Gaito, Love Goyal, Romelie Rieu, et al.
The British Journal of Radiology|July 25, 2015
Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancerJessica E Scaife, Simon J Thomas, Karl Harrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2015
Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy ToxicityLeila Dorling, Gillian C Barnett, Kyriaki Michailidou, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2014
Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trialMukesh B Mukesh, Wendi Qian, Jennifer S Wilkinson, et al.
European Journal of Endocrinology|August 7, 2015
A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndromeOlympia Koulouri, Andrea Steuwe, Daniel Gillett, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 4, 2021
Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy?Brita S Sørensen, Jörg Pawelke, Julia Bauer, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Physics and Imaging in Radiation Oncology|June 26, 2020
Associations between voxel-level accumulated dose and rectal toxicity in prostate radiotherapyLeila E A Shelley, Michael P F Sutcliffe, Simon J Thomas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2009
A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry resultsGillian C Barnett, Jennifer Wilkinson, Anne M Moody, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2010
No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER studyGillian C Barnett, Charlotte E Coles, Neil G Burnet, et al.
The British Journal of Radiology|December 21, 2019
Proton beam therapy: perspectives on the National Health Service England clinical service and research programmeNeil G Burnet, Ranald I Mackay, Ed Smith, et al.
Neuro-Oncology Practice|March 18, 2024
Radiotherapy intensification for atypical and malignant meningiomas: A systematic reviewSimona Gaito, Love Goyal, Romelie Rieu, et al.
The British Journal of Radiology|July 25, 2015
Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancerJessica E Scaife, Simon J Thomas, Karl Harrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2015
Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy ToxicityLeila Dorling, Gillian C Barnett, Kyriaki Michailidou, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2014
Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trialMukesh B Mukesh, Wendi Qian, Jennifer S Wilkinson, et al.
European Journal of Endocrinology|August 7, 2015
A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndromeOlympia Koulouri, Andrea Steuwe, Daniel Gillett, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 4, 2021
Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy?Brita S Sørensen, Jörg Pawelke, Julia Bauer, et al.
Pageof 8